Market Overview:
The global addictions therapeutics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of addiction, rising awareness about available treatments, and growing demand for better and more effective therapies. The global addictions therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics. On the basis of application, the market is segmented into public sector (government-funded institutions), private sector (non-profit organizations/NGOs), and third sector (self-help groups). The North America region dominates the global addictions therapeutics market followed by Europe due to high prevalence rate of various types of addictions in these regions.
Product Definition:
Addictions Therapeutics is the branch of pharmacology that deals with the study and treatment of addiction. It is important because it helps to treat people who are addicted to drugs or alcohol.
Alcohol Addiction Therapeutics:
Alcohol addiction therapeutics, also known as pharmacotherapy for alcohol dependence or ethanol abuse, is a form of medical therapy used to treat an individual addicted to alcohol. Alcohol addiction can be characterized by compulsive drinking and recurrent alcoholic beverages consumption despite adverse consequences. The most common symptoms associated with alcohol addiction include impaired control over drinking, continued to drink even when it causes harm or discomfort, and increased tolerance towards the effects of alcohol on the body.
Tobacco Addiction Therapeutics:
Tobacco addiction therapeutics is a drug that is used to treat nicotine addiction. It works by reducing the effects of nicotine in the brain, thereby preventing compulsive smoking. Currently, two types of drugs are approved for smoking cessation: Zyban (Bupropion) and Varenicline (Chantix). Both these drugs have been authorized by the U.
Application Insights:
The public application segment dominated the global addictions therapeutics market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to growing awareness about substance abuse among individuals, coupled with rising government initiatives against drug abuse. For instance, according to a survey conducted by the National Institute on Drug Abuse (NIDA), around 20% of adults in U.S., have admitted that they had an addiction problems with drugs or alcohol at some point in their life. However, only 9% of them reported about it to a healthcare professional while 7% sought help from religious leaders and 5% turned towards friends for support during treatment sessions. Such statistics indicate that there is still room for improvement when it comes time educating people about substance abuse issues so that they seek help before it gets out of hand and causes irreparable damage to their health & well-being as well as careers/livelihoods.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period as well owing to factors such as a rise in disposable income, high prevalence of addictions, and availability of effective treatment methods. Moreover, government initiatives for increasing awareness about addiction disorders are also driving regional growth. For instance, Health Canada’s licensing and regulation division monitors prescription drug sales through pharmacies and doctors' offices along with other measures taken against illegal drug use within Canada.
The Asia Pacific is anticipated to be the fastest-growing region during the forecast period due to rising cases of substance abuse among patients from China & India coupled with growing awareness about available treatment options amongst these countries population especially amongst millennials & Generation Z (born between 1995 & 2010). In addition, increasing efforts by private companies for capitalizing on this untapped market opportunity are also expected drive regional growth over next eight years (2030).
Growth Factors:
- Increasing prevalence of addiction: The number of people addicted to drugs and alcohol is increasing at an alarming rate. This is driving the demand for addiction therapies.
- Growing awareness about addiction therapies: There is growing awareness among people about the availability and benefits of various types of addiction therapies. This is helping to drive the growth of the market.
- Rising incidence of co-occurring disorders: A large number of people who are addicted to drugs or alcohol also suffer from other mental health disorders such as depression, anxiety, etc. This is driving the demand for co-occurring disorder treatments, which in turn is boosting the growth of the addictions therapeutics market.
- Technological advancements in treatment methods: There has been a significant advancement in treatment methods for addictions in recent years due to technological innovations such as gene therapy and nanotechnology-based treatments For instance, there are now a number if effective medications available that can help manage different types addictive behaviors .This is helping to propelthe growthof thismarket segment . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Addictions Therapeutics Market Research Report
By Type
Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics
By Application
Public, Private, Government
By Companies
Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Addictions Therapeutics Market Report Segments:
The global Addictions Therapeutics market is segmented on the basis of:
Types
Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Public, Private, Government
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alkermes Plc
- Amneal Pharmaceuticals Inc.
- Indivior Plc
- Johnson & Johnson Services Inc.
- Mylan NV
- Novartis AG
- Novo Nordisk AS
- Opiant Pharmaceuticals Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Highlights of The Addictions Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Alcohol Addiction Therapeutics
- Tobacco Addiction Therapeutics
- Drug Addiction Therapeutics
- By Application:
- Public
- Private
- Government
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Addictions Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Addictions Therapeutics is a clinical research company that specializes in the development of novel addiction therapies. The company's mission is to help people suffering from addiction and related disorders by developing innovative treatments that address the root causes of these problems. Addiction Therapeutics also aims to educate others about addiction and its effects so that they can make informed decisions about how to best support those affected by it.
Some of the key players operating in the addictions therapeutics market are Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd..
The addictions therapeutics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Addictions Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Addictions Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Addictions Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Addictions Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Addictions Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Addictions Therapeutics Market Size and Y-o-Y Growth
4.5.2 Addictions Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Addictions Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Addictions Therapeutics Market Size Forecast by Type
5.2.1 Alcohol Addiction Therapeutics
5.2.2 Tobacco Addiction Therapeutics
5.2.3 Drug Addiction Therapeutics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Addictions Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Addictions Therapeutics Market Size Forecast by Applications
6.2.1 Public
6.2.2 Private
6.2.3 Government
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Addictions Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Addictions Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Addictions Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Addictions Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Addictions Therapeutics Market Size Forecast by Type
9.6.1 Alcohol Addiction Therapeutics
9.6.2 Tobacco Addiction Therapeutics
9.6.3 Drug Addiction Therapeutics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Addictions Therapeutics Market Size Forecast by Applications
9.10.1 Public
9.10.2 Private
9.10.3 Government
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Addictions Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Addictions Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Addictions Therapeutics Market Size Forecast by Type
10.6.1 Alcohol Addiction Therapeutics
10.6.2 Tobacco Addiction Therapeutics
10.6.3 Drug Addiction Therapeutics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Addictions Therapeutics Market Size Forecast by Applications
10.10.1 Public
10.10.2 Private
10.10.3 Government
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Addictions Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Addictions Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Addictions Therapeutics Market Size Forecast by Type
11.6.1 Alcohol Addiction Therapeutics
11.6.2 Tobacco Addiction Therapeutics
11.6.3 Drug Addiction Therapeutics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Addictions Therapeutics Market Size Forecast by Applications
11.10.1 Public
11.10.2 Private
11.10.3 Government
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Addictions Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Addictions Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Addictions Therapeutics Market Size Forecast by Type
12.6.1 Alcohol Addiction Therapeutics
12.6.2 Tobacco Addiction Therapeutics
12.6.3 Drug Addiction Therapeutics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Addictions Therapeutics Market Size Forecast by Applications
12.10.1 Public
12.10.2 Private
12.10.3 Government
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Addictions Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Addictions Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Addictions Therapeutics Market Size Forecast by Type
13.6.1 Alcohol Addiction Therapeutics
13.6.2 Tobacco Addiction Therapeutics
13.6.3 Drug Addiction Therapeutics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Addictions Therapeutics Market Size Forecast by Applications
13.10.1 Public
13.10.2 Private
13.10.3 Government
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Addictions Therapeutics Market: Competitive Dashboard
14.2 Global Addictions Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alkermes Plc
14.3.2 Amneal Pharmaceuticals Inc.
14.3.3 Indivior Plc
14.3.4 Johnson & Johnson Services Inc.
14.3.5 Mylan NV
14.3.6 Novartis AG
14.3.7 Novo Nordisk AS
14.3.8 Opiant Pharmaceuticals Inc.
14.3.9 Pfizer Inc.
14.3.10 Teva Pharmaceutical Industries Ltd.
